about
Mucociliary clearance: pathophysiological aspectsGene expression of ANP, BNP and ET-1 in the heart of rats during pulmonary embolismBiopsy-Verified Bronchiolitis Obliterans and Other Noninfectious Lung Pathologies after Allogeneic Hematopoietic Stem Cell TransplantationFeasibility of Real-Time Near-Infrared Fluorescence Tracer Imaging in Sentinel Node Biopsy for Oral Cavity Cancer Patients.Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review.The single-breath diffusing capacity of CO and NO in healthy children of European descentEffects of soccer vs swim training on bone formation in sedentary middle-aged women.Clinical value of measurement of pulmonary radioaerosol mucociliary clearance in the work up of primary ciliary dyskinesia.Positron-emission tomography in prognostic and therapeutic assessment of lung cancer: systematic review.Radiological patterns of primary graft dysfunction after lung transplantation evaluated by 64-multi-slice computed tomography: a descriptive study.Scintigraphy at 3 months after single lung transplantation and observations of primary graft dysfunction and lung function.Lung function 22-35 years after treatment of idiopathic spontaneous pneumothorax with talc poudrage or simple drainage.Expert Nordic perspectives on the potential of novel inhalers to overcome unmet needs in the management of obstructive lung disease.(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2Imaging in chronic obstructive pulmonary disease.Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life.Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle functionA comparison of endoscopic ultrasound guided biopsy and positron emission tomography with integrated computed tomography in lung cancer staging.uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.SPECT/CT and pulmonary embolism.Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours.Mucociliary clearance in the lung.Methodology for ventilation/perfusion SPECT.Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art.Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases-analysis of an international multicenter database.Pulmonary thromboembolism as a complication of lung transplantation.The optimality of different strategies for supplemental staging of non-small-cell lung cancer: a health economic decision analysis.Need for intensive histopathologic analysis to determine lymph node metastases when using sentinel node biopsy in oral cancer.Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?Pulmonary function and fitness years after treatment for hypersensitivity pneumonitis during childhood.How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study.Clinical utility of 18F-FDG positron emission tomography/computed tomography scan vs. 99mTc-HMPAO white blood cell single-photon emission computed tomography in extra-cardiac work-up of infective endocarditis.Missing head and color banding in low-count SPECT reconstructions.Staging of early lymph node metastases with the sentinel lymph node technique and predictive factors in T1/T2 oral cavity cancer: A retrospective single-center study.High-intensity intermittent swimming improves cardiovascular health status for women with mild hypertension.Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.64Cu-DOTATATE for Noninvasive Assessment of Atherosclerosis in Large Arteries and Its Correlation with Risk Factors: Head-to-Head Comparison with 68Ga-DOTATOC in 60 Patients.Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.Prevalence of cerebral and pulmonary thrombosis in patients with cyanotic congenital heart disease.
P50
Q27022272-CB572750-B4C1-4479-9F91-6171318D9C17Q28751573-60B71BD7-51C0-4801-9646-E72EB6426A21Q30160773-6719260B-D974-48C2-A65B-50A9F2C60F79Q30392856-B0669AC2-7F4B-4FEF-8519-3ED81AC18C7AQ34569986-1B13B3A8-FD92-4048-860E-A19250F9FF9DQ34712859-B7603F7D-458A-41F7-8508-70D6422384FFQ35740603-168B88B3-FAD2-4944-93F9-81A9FCCAD7B8Q35855793-1BEF5D3B-45AA-46FD-B6B9-A7D251E9F9A8Q35874704-D4D92307-C215-42D5-805A-DF9F7C07334BQ35961852-B6D7848D-B0A5-4AB0-9BC5-78864E5BEA51Q35961856-9B383371-DB50-4C65-B566-F901CDAB703BQ36185240-E98462B2-9D0C-494D-9C40-F87E2ABD01E4Q36385515-4BDA1C12-5DC9-42C7-BAA9-5A49B7A15758Q36568335-0734AEA0-11FD-4EE0-B4CC-8765CDBBFBBEQ36832380-B5DEEA1B-F96C-4B7F-84F9-166D8836F3E8Q37253453-8DAD73DC-82AF-4997-B64D-7B1507E57173Q37311786-29F6F8AB-746D-4489-A88B-C042C9F9128DQ37622430-AEA517F5-F38F-449D-A85C-AFD5DB179AE9Q37716562-4DC884D5-48A0-4870-A518-CE3945540A53Q37730011-01EA6F3B-2AB5-4DB8-9335-15D8E5CA98C4Q37765569-370F51DE-3277-42A3-82E1-29FB005D5BAAQ37782755-C5ED6AB4-7677-46E4-94CD-65285CA7B6B6Q37797655-CBAB9A76-99C4-4BE3-B5D5-3711872F932CQ38241601-7DD10D5C-3E48-4D01-9F6C-F4514EC93FD2Q38557054-145675E7-BEB3-4A53-B1BB-576AF015A3EDQ38937691-4C7B0950-4C09-4B02-AD4F-5F804A29E1DCQ39114920-D9BF6372-3DBC-4432-9045-F61E11547AD9Q39481653-E91FA863-1DA7-4C08-B489-9B3912BE2EF8Q40149523-1D855DA7-EAB4-4644-91C7-016D76612F51Q40153117-E0795432-A98B-4CCE-A5C3-8791E238AEE1Q40201283-5D51F401-D556-4B57-9150-0409D916A311Q40292903-0C4BEB75-5ECC-46A1-9B53-E7A5D87D7F36Q40386335-82D04165-8FD2-4C8E-A95D-8782AE43AAC3Q40392857-A99C5E3B-640F-4C48-9A05-EE5897A8BE7DQ40872827-C0E6E9DE-C623-4E42-99AD-8985EC393D43Q41129593-A36612E6-2A3A-4778-8098-16508FD2996DQ41199112-221E6AC6-5833-4950-9847-2769116C135EQ41272212-9E469D16-131A-4AE4-BEB0-9E11112F4290Q41542151-99C7685D-8BB5-49A9-8F3B-C41CB795E3C4Q41689979-3FE39BB7-EE07-4DFF-A187-01B973F30E39
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jann Mortensen
@ast
Jann Mortensen
@en
Jann Mortensen
@es
Jann Mortensen
@nl
Jann Mortensen
@sl
type
label
Jann Mortensen
@ast
Jann Mortensen
@en
Jann Mortensen
@es
Jann Mortensen
@nl
Jann Mortensen
@sl
prefLabel
Jann Mortensen
@ast
Jann Mortensen
@en
Jann Mortensen
@es
Jann Mortensen
@nl
Jann Mortensen
@sl
P106
P108
P31
P496
0000-0002-1399-8995